Medicamen Biotech Limited — Others, 29-07-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

Medicamen Biotech Limited has confirmed its adherence to share transfer regulations for the quarter ending June 30, 2025. The company ensures that all shares submitted by investors for conversion from physical to electronic form were properly processed, verified, and recorded with depositories. Physical certificates were cancelled, and digital ownership updated within the required timeframe. This confirms robust internal processes for maintaining accurate shareholder records and facilitating secure, efficient share transactions for investors.